Derivative Warrants | ALIHEA28C2402A | DERIVATIVE CALL WARRANTS ON ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED (241) ISSUED BY MACQUARIE SECURITIES (THAILAND) LIMITED LAST TRADING IN FEBRUARY 2024
Derivative Warrants | ALIHEA41C2601A | DERIVATIVE CALL WARRANTS ON ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED (241) ISSUED BY JPMORGAN SECURITIES (THAILAND) LIMITED LAST TRADING IN JANUARY 2026
Derivative Warrants | ALIHEA41C2310A | DERIVATIVE CALL WARRANTS ON ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED (241) ISSUED BY JPMORGAN SECURITIES (THAILAND) LIMITED LAST TRADING IN OCTOBER 2023
. Clause 3. In order to ensure that representatives shall render services with honesty and due care for the best interest of investors as well as provide appropriate and adequate information in line with
office. Clause 3. In order to ensure that representatives shall render services with honesty and due care for the best interest of investors as well as provide appropriate and adequate information in line
as provide appropriate and adequate information in line with standards of services of the management company, in appointing a representative under Clause 2, the management company shall proceed as
Dissemination of Information Relating to Securities Offering Prior to the Effectiveness of Registration Statement and Draft Prospectus (No. 2)
Dissemination of Information Relating to Securities Offering Prior to the Effectiveness of Registration Statement and Draft Prospectus (No. 3)
Rules, Conditions and Procedures for Disclosure of Financial and Non-financial Information of Securities Issuers (No. 4)
Practical Guidelines on Disclosure of Information for Sustainable and Responsible Investing Funds (Attachment to Practical Guidelines No. Nor.Por. 2/2565)